Clinical Trial Update: Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic interaction study of tadalafil and dutasteride in benign prostatic hyperplasia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Dongkook Pharmaceutical Co., Ltd. | Conditions: Benign Prostate Hyperplasia | Phase 1 | Status: COMPLETED